Intraductal Papillary Mucinous Neoplasm of the Pancreas
📧 Sign up to get email alerts when something new happens for Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia. [Phase 3]
Phase 3 clinical trial examining aspiration methods for molecular analysis in intraductal papillary mucinous neoplasm of the pancreas.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: 18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas [NA]
Completed clinical trial evaluating 18-FDG PET-CT for diagnosing degeneration in intraductal papillary mucinous neoplasm of the pancreas.
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery [Phase 2]
Phase 2 study of erlotinib in pancreatic cancer that can be removed by surgery was terminated; results have been posted.